{"title":"经前综合症-影响问卷：土耳其版本的跨文化适应、信度和效度。","authors":"Halime Arıkan, Erkan Erol","doi":"10.1590/1516-3180.2024.0288.R1.07042025","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Short and practical questionnaires and tests that assess premenstrual symptoms and premenstrual syndrome (PMS) are required.</p><p><strong>Objectives: </strong>This study aimed to investigate the cross-cultural adaptation, validity, and reliability of the Premenstrual Syndrome Impact Questionnaire (PMS-IQ) in Turkish women with PMS.</p><p><strong>Design and setting: </strong>The reliability and validity of the questionnaire were evaluated in Tokat, Türkiye.</p><p><strong>Methods: </strong>A convenience sample of 146 individuals diagnosed with PMS was used to assess the reliability and validity of the Turkish version of the PMS-IQ. Test-retest analyses were performed in a subset of 96 individuals one week after the initial assessment. Construct validity was evaluated through convergent validity analysis using the Premenstrual Syndrome Scale (PMSS) and the Premenstrual Symptoms Impact Survey (PMSIS), and divergent validity analysis with the Big Five Inventory-10 (BFI-10).</p><p><strong>Results: </strong>Cronbach's α values for the total score and subscales ranged from 0.861 to 0.917, whereas the test-retest reliability values ranged from 0.755 to 0.847. Factor analysis indicated that the scale had a three-factor structure. The total PMS-IQ score was significantly correlated with both the PMSS (r = 0.718) and PMSIS (r = 0.774), but showed no significant correlation with the BFI-10 (r = 0.113). No floor or ceiling effects were observed for the total or subscale scores of the PMS-IQ.</p><p><strong>Conclusions: </strong>The Turkish version of the PMS-IQ demonstrated reliability and validity for evaluating individuals with PMS.</p><p><strong>Clinical trial registration: </strong>This study is registered at ClinicalTrials.gov (identifier: NCT05725447).</p>","PeriodicalId":49574,"journal":{"name":"Sao Paulo Medical Journal","volume":"143 5","pages":"e2024288"},"PeriodicalIF":1.6000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12440256/pdf/","citationCount":"0","resultStr":"{\"title\":\"Premenstrual Syndrome-Impact Questionnaire: Cross-cultural adaptation, reliability, and validity of the Turkish version.\",\"authors\":\"Halime Arıkan, Erkan Erol\",\"doi\":\"10.1590/1516-3180.2024.0288.R1.07042025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Short and practical questionnaires and tests that assess premenstrual symptoms and premenstrual syndrome (PMS) are required.</p><p><strong>Objectives: </strong>This study aimed to investigate the cross-cultural adaptation, validity, and reliability of the Premenstrual Syndrome Impact Questionnaire (PMS-IQ) in Turkish women with PMS.</p><p><strong>Design and setting: </strong>The reliability and validity of the questionnaire were evaluated in Tokat, Türkiye.</p><p><strong>Methods: </strong>A convenience sample of 146 individuals diagnosed with PMS was used to assess the reliability and validity of the Turkish version of the PMS-IQ. Test-retest analyses were performed in a subset of 96 individuals one week after the initial assessment. Construct validity was evaluated through convergent validity analysis using the Premenstrual Syndrome Scale (PMSS) and the Premenstrual Symptoms Impact Survey (PMSIS), and divergent validity analysis with the Big Five Inventory-10 (BFI-10).</p><p><strong>Results: </strong>Cronbach's α values for the total score and subscales ranged from 0.861 to 0.917, whereas the test-retest reliability values ranged from 0.755 to 0.847. Factor analysis indicated that the scale had a three-factor structure. The total PMS-IQ score was significantly correlated with both the PMSS (r = 0.718) and PMSIS (r = 0.774), but showed no significant correlation with the BFI-10 (r = 0.113). No floor or ceiling effects were observed for the total or subscale scores of the PMS-IQ.</p><p><strong>Conclusions: </strong>The Turkish version of the PMS-IQ demonstrated reliability and validity for evaluating individuals with PMS.</p><p><strong>Clinical trial registration: </strong>This study is registered at ClinicalTrials.gov (identifier: NCT05725447).</p>\",\"PeriodicalId\":49574,\"journal\":{\"name\":\"Sao Paulo Medical Journal\",\"volume\":\"143 5\",\"pages\":\"e2024288\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12440256/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sao Paulo Medical Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1590/1516-3180.2024.0288.R1.07042025\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sao Paulo Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1590/1516-3180.2024.0288.R1.07042025","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Premenstrual Syndrome-Impact Questionnaire: Cross-cultural adaptation, reliability, and validity of the Turkish version.
Background: Short and practical questionnaires and tests that assess premenstrual symptoms and premenstrual syndrome (PMS) are required.
Objectives: This study aimed to investigate the cross-cultural adaptation, validity, and reliability of the Premenstrual Syndrome Impact Questionnaire (PMS-IQ) in Turkish women with PMS.
Design and setting: The reliability and validity of the questionnaire were evaluated in Tokat, Türkiye.
Methods: A convenience sample of 146 individuals diagnosed with PMS was used to assess the reliability and validity of the Turkish version of the PMS-IQ. Test-retest analyses were performed in a subset of 96 individuals one week after the initial assessment. Construct validity was evaluated through convergent validity analysis using the Premenstrual Syndrome Scale (PMSS) and the Premenstrual Symptoms Impact Survey (PMSIS), and divergent validity analysis with the Big Five Inventory-10 (BFI-10).
Results: Cronbach's α values for the total score and subscales ranged from 0.861 to 0.917, whereas the test-retest reliability values ranged from 0.755 to 0.847. Factor analysis indicated that the scale had a three-factor structure. The total PMS-IQ score was significantly correlated with both the PMSS (r = 0.718) and PMSIS (r = 0.774), but showed no significant correlation with the BFI-10 (r = 0.113). No floor or ceiling effects were observed for the total or subscale scores of the PMS-IQ.
Conclusions: The Turkish version of the PMS-IQ demonstrated reliability and validity for evaluating individuals with PMS.
Clinical trial registration: This study is registered at ClinicalTrials.gov (identifier: NCT05725447).
期刊介绍：
Published bimonthly by the Associação Paulista de Medicina, the journal accepts articles in the fields of clinical health science (internal medicine, gynecology and obstetrics, mental health, surgery, pediatrics and public health). Articles will be accepted in the form of original articles (clinical trials, cohort, case-control, prevalence, incidence, accuracy and cost-effectiveness studies and systematic reviews with or without meta-analysis), narrative reviews of the literature, case reports, short communications and letters to the editor. Papers with a commercial objective will not be accepted.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
